Elanco Animal Health Inc

Elanco Animal Health develops, manufactures, and markets pharmaceutical products for companion animals and livestock across more than 100 countries. The company's portfolio spans parasiticides, vaccines, therapeutics, and medicated feed additives designed to address health conditions ranging from flea and tick prevention to pain management and infectious disease control. Key companion animal brands include Seresto, Advantix, Credelio, and Galliprant, while farm animal products are marketed under trademarks such as Rumensin, Baytril, and AviPro for cattle, swine, and poultry applications.

The business operates through two primary segments: companion animal health and farm animal products. Companion animal offerings focus on preventive and therapeutic treatments for dogs and cats sold through veterinary clinics, distributors, and retailers. Farm animal products address disease prevention and production efficiency in livestock operations, with customers ranging from individual producers to large farming operations. Products are distributed both directly to producers and veterinarians and through third-party distributors and independent retailers.

Headquartered in Indianapolis, Indiana, Elanco employs approximately 9,400 full-time employees. The company maintains manufacturing and research operations across multiple geographies to support its global customer base in both developed and emerging markets.